Sirona Biochem (STU:ZSB) EBITDA Margin %: -22,250.00% (As of Jul. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Sirona Biochem EBITDA Margin %?

Sirona Biochem STU:ZSB EBITDA Margin % is -22,250.00% as of Jul. 2024.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sirona Biochem's EBITDA for the three months ended in Jul. 2024 was €-0.45 Mil. Sirona Biochem's Revenue for the three months ended in Jul. 2024 was €0.00 Mil. Therefore, Sirona Biochem's EBITDA margin for the quarter that ended in Jul. 2024 was -22,250.00%.

Sirona Biochem  (STU:ZSB) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Sirona Biochem EBITDA Margin % Related Terms

Sirona Biochem EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Sirona Biochem's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sirona Biochem EBITDA Margin % Chart

Sirona Biochem Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,272.04 -3,894.12 -856.99 -523.49 -6,712.50

Sirona Biochem Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6,100.00 1,586.36 -45,300.00 -4,085.71 -22,250.00

STU:ZSB vs MTNB, TCRT, QLGN: EBITDA Margin % Comparison

For the Biotechnology subindustry, Sirona Biochem's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sirona Biochem EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirona Biochem's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Sirona Biochem's EBITDA Margin % falls into.


Sirona Biochem EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Sirona Biochem's EBITDA Margin % for the fiscal year that ended in Oct. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Oct. 2023 )/Revenue (A: Oct. 2023 )
=-1.611/0.024
=-6,712.50 %

Sirona Biochem's EBITDA Margin % for the quarter that ended in Jul. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jul. 2024 )/Revenue (Q: Jul. 2024 )
=-0.445/0.002
=-22,250.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -22,250.00% mean?
Sirona Biochem (STU:ZSB) has a EBITDA Margin % of -22,250.00% as of Jul. 2024. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sirona Biochem and its competitors.
Is Sirona Biochem's EBITDA Margin % too high?
Sirona Biochem's current EBITDA Margin % is -22,250.00%.
How does Sirona Biochem's EBITDA Margin % compare to MTNB and TCRT?
Sirona Biochem's EBITDA Margin % of -22,250.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sirona Biochem and its competitors. Sirona Biochem's current EBITDA Margin % is -22,250.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sirona Biochem stock overvalued right now?
Sirona Biochem (STU:ZSB) has a current EBITDA Margin % of -22,250.00%. The current EBITDA Margin % is -22,250.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Sirona Biochem (STU:ZSB), the current EBITDA Margin % is -22,250.00% as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sirona Biochem Business Description

Address C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L4
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. The company has a business presence in Canada and France.